These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23815956)

  • 1. Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?
    Gupta AK; Brintnell WC
    J Cutan Med Surg; 2013; 17(4):243-9. PubMed ID: 23815956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichophyton mentagrophytes using an in vitro test system.
    Gupta AK; Brintnell W
    J Dermatolog Treat; 2014 Jun; 25(3):251-5. PubMed ID: 22827529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device.
    Ghannoum MA; Isham N; Long L
    J Am Podiatr Med Assoc; 2012; 102(4):309-13. PubMed ID: 22826329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Trichophyton spp. from footwear of patients with tinea pedis.
    Ishijima SA; Hiruma M; Sekimizu K; Abe S
    Drug Discov Ther; 2019; 13(4):207-211. PubMed ID: 31534072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
    Skaastrup KN; Astvad KMT; Arendrup MC; Jemec GBE; Saunte DML
    Mycoses; 2022 Jul; 65(7):741-746. PubMed ID: 35535729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Prevention of reinfection in foot mycoses].
    Steigleder GK; Klenk-Pfeufer E
    Dtsch Med Wochenschr; 1974 Aug; 99(35):1744. PubMed ID: 4277869
    [No Abstract]   [Full Text] [Related]  

  • 7. The March Against Onychomycosis: A Systematic Review of the Sanitization Methods for Shoes, Socks, and Textiles.
    Gupta AK; Simkovich AJ; Hall DC
    J Am Podiatr Med Assoc; 2022; 112(4):. PubMed ID: 36074338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing and treating onychomycosis.
    Zaias N; Glick B; Rebell G
    J Fam Pract; 1996 May; 42(5):513-8. PubMed ID: 8642370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B; Caldwell B
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission of two feet-one hand syndrome.
    Seeburger J; Scher RK
    Cutis; 1998 Mar; 61(3):149-51. PubMed ID: 9538957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea and Onychomycosis.
    Rosen T
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non-insulin-dependent diabetes mellitus: a case-control study.
    Ozcan D; Seçkin D; Demirbilek M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1442-6. PubMed ID: 20384680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-voltage direct current as a fungicidal agent for treating onychomycosis.
    Kalinowski DP; Edsberg LE; Hewson RA; Johnson RH; Brogan MS
    J Am Podiatr Med Assoc; 2004; 94(6):565-72. PubMed ID: 15547124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal environment of footwear is a risk factor for tinea pedis.
    Sasagawa Y
    J Dermatol; 2019 Nov; 46(11):940-946. PubMed ID: 31436337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid real-time diagnostic PCR for Trichophyton rubrum and Trichophyton mentagrophytes in patients with tinea unguium and tinea pedis using specific fluorescent probes.
    Miyajima Y; Satoh K; Uchida T; Yamada T; Abe M; Watanabe S; Makimura M; Makimura K
    J Dermatol Sci; 2013 Mar; 69(3):229-35. PubMed ID: 23287391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: Strategies to Minimize Recurrence.
    Gupta AK; Elewski BE; Rosen T; Caldwell B; Pariser DM; Kircik LH; Bhatia N; Tosti A
    J Drugs Dermatol; 2016 Mar; 15(3):279-82. PubMed ID: 26954312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer preferences of antifungal products for treatment and prevention of tinea pedis.
    Kang R; Lipner S
    J Dermatolog Treat; 2019 Dec; 30(8):745-749. PubMed ID: 30661432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of superficial mycosis (tinea pedis, onychomycosis) in elementary school children in Istanbul, Turkey.
    Hapcioglu B; Yegenoglu Y; Disci R; Erturan Z; Kaymakcalan H
    Coll Antropol; 2006 Mar; 30(1):119-24. PubMed ID: 16617585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteolytic activity of strains of T. mentagrophytes and T. rubrum isolated from tinea pedis and tinea unguium infections.
    Samdani AJ; Dykes PJ; Marks R
    J Med Vet Mycol; 1995; 33(3):167-70. PubMed ID: 7666296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.